Econ-546 · economics · Economics

Econ-546

Democratizing innovation

LLM status Partially solved unverified

O38 — Government Policy Economics catalogue openaigpt 6 astra ultra 50% cataloguednot recordedPartially solved

Statement

Original subject group: Innovation and AI economics

Audit classification: Explicit published open question. The publication explicitly asks about access democratization. The original term change in the gap had a sign ambiguity and access was not distinguished from use.

Definitions and precise research target

Consider firms eligible for a public AI research-access program, partitioned before treatment into small firms $G=s$ and resource-rich incumbents $G=l$ using a stated employment threshold. Let $A=1$ provide an identical subsidized model, computation allowance and training package, while $A=0$ retains existing access. Over three years, define $Y_i(a)$ as the value of independently validated new products from firm $i$, with zero for nonparticipation or unsuccessful research. Group effects are \[ \tau_g=E[Y_i(1)-Y_i(0)\mid G=g],\qquad g\in\{s,l\}, \] and the closure of the incumbent-minus-small average innovation gap is $\Gamma=\tau_s-\tau_l$. This gap does not itself measure aggregate welfare, so separately record entry, exit, innovation expenditure and product diffusion. Use program eligibility lotteries or clustered rollout with recorded access compliance; account for knowledge spillovers and changes in incumbent competition within product markets. Define a market-level policy effect by assigning access to all eligible firms in a market and measuring total validated value net of program resource costs. Which access and support arrangements make $\Gamma>0$ while increasing this aggregate outcome? The scope is eligible firms in the selected sectors, with uncertainty about commercialization and crowding out explicitly measured rather than an unrestricted claim that AI democratizes innovation.

Definitions, assumptions and mathematical qualifications. Group membership is fixed at baseline. Define $\mu_g(a)=E[Y_i(a)\mid G=g]$. The incumbent-minus-small mean gap is $D(a)=\mu_l(a)-\mu_s(a)$, and $\Gamma=D(0)-D(1)=\tau_s-\tau_l$ is gap closure; it is not the signed change $D(1)-D(0)$. Assignment to the access package, actual use and successful innovation are separate variables. Define the policy effect at the product-market level, with market-wide eligibility and potential knowledge spillovers, to evaluate commercialization and displacement. A larger small-firm effect alone need not imply a positive aggregate resource-adjusted effect.

Variants and assumption changes

  1. Editorial, intention to treat. Lottery assignment identifies group-specific package effects including nonuse, under groupwise assignment positivity; estimate gap closure without an exclusion assumption.
  2. Editorial, policy saturation. Randomize whole markets to universal eligible-firm access and compare total validated value less program and research costs, allowing incumbents to respond and products to displace each other.

References and source audit

Checked source. 2024 Stanford draft, Section 3.2, PDF pp. 10--11. Full primary draft and cover retrieved. https://digitaleconomy.stanford.edu/app/uploads/2024/11/ETAI-White-Paper.pdf.
  1. Erik Brynjolfsson; Anton Korinek; Ajay Agrawal. 2024. The Economics of Transformative AI: A Research Agenda. 2024 Stanford draft, Section 3.2, PDF pp. 10--11. https://digitaleconomy.stanford.edu/app/uploads/2024/11/ETAI-White-Paper.pdf.

Common conventions: Source mathematical conventions

These conventions apply to each entry unless explicitly replaced.

Models and identification. A primitive model $m$ specifies all probability laws, feasible choices, information, equilibrium and measurement rules used by its target. The admissible class $\mathcal M$ is fixed independently of outcomes. If $P_O(m)$ is its observable probability law and $\tau(m)$ the target, its identified set at observable law $P$ is \[ \mathcal I_\tau(P)=\{\tau(m):m\in\mathcal M,\ P_O(m)=P\}. \] Point identification means that this set is a singleton. An empty set signals incompatibility of data and assumptions. Coordinate bounds need not describe the joint set. Bounds are sharp only if every retained target is attainable or arbitrarily approachable by compatible models. Finite bounds require explicit restrictions on unobserved quantities; unrestricted confounding, hidden wealth, extrapolation or arbitrary equilibrium selection can yield uninformative sets.

Causal interventions. A potential outcome $Y_i(p)$ is the outcome under a complete policy regime $p$, including timing, financing, information and market spillovers. The target population and units are fixed before treatment. With interference, use the complete assignment vector or a justified exposure mapping; individual no-interference notation alone cannot identify an economy-wide intervention. A difference of mean potential outcomes does not require the cross-world joint distribution. Conditioning on post-treatment migration, survival, enrollment or employment changes the estimand and needs separate justification.

Statistical statements. An estimator, confidence set, forecast or test specifies a sampling law, model class and loss/coverage criterion. Uniform $(1-\alpha)$-coverage means $\inf_{m\in\mathcal M}\Pr_m\{\tau(m)\in C_n\}\geq1-\alpha$, or an explicitly asymptotic version. The whole parameter space trivially has coverage, so informativeness requires a stated width, risk or power objective. A forecasting improvement is relative to a named benchmark, information set and evaluation population.

Equilibrium and optimization. An equilibrium comprises feasible plans, optimality, beliefs where needed, budget constraints and all market/resource clearing. The primitives or a stated benchmark define each correspondence $\mathcal E(p;m)$. Nonemptiness is assumed or proved, never inferred just from compact policy sets. A selected-equilibrium target uses a declared selection rule; a robust target quantifies over all permitted equilibria. Use suprema or infima unless attainment is established. An $\varepsilon$-optimal policy is feasible and within $\varepsilon$ of the finite optimum value. Report an empty feasible set separately.

Welfare and accounting. Normative utility, interpersonal normalization, social weights, numeraire, discounting and the use of public receipts are primitives. Behavioral utility need not coincide with the welfare criterion. Household welfare includes ownership income and rents once; adding profits again to compensating variation generally double-counts them. A monetary equivalent is defined by an explicit transfer and price convention, with monotonicity and range conditions. Average effects, mechanism contributions, transfers and welfare losses are different targets. Infinite sums require convergence and dynamic feasible plans require terminal or no-Ponzi conditions.

Source versions. A working-paper date, revision date and journal publication year are distinguished. A DOI for a journal version is not automatically the DOI of an earlier manuscript. Locators refer to the stated version and printed pages where specified. A metadata-only check does not verify a claim about a full-text conclusion. Every entry's source subsection narrows the provenance claim accordingly.

Statement licence: CC-BY-4.0 · Source file

Contributions 1

Econ-546-A1 · Partial result · LLM-generated · gpt 6 astra ultra ·

GPT 6 Astra Ultra attempt on Econ-546

Gap closure, complementary investment, and aggregate innovation value

Status: Partial; the full catalogue target remains unresolved.

Abstract

A simple research-investment model shows why equal access can increase small-firm validated output more than incumbent output while its aggregate resource-adjusted value has either sign. Randomized access identifies baseline-group intention-to-treat effects and the gap-closure contrast. Actual-use effects and market-wide scaling remain distinct estimands. A finite set of simultaneous cell bounds supplies an honest sign and welfare certificate.

The population and its two comparisons

Fix eligible firms and their baseline group $G\in\{s,l\}$. Let $Y(a)$ be independently validated new-product value after three years under access package $a$, including zeros for unsuccessful research and nonparticipation. The package fixes model capability, computation allowance, and training. Group effects are $\tau_g={\mathbb{E}}[Y(1)-Y(0)\mid G=g]$. The incumbent-minus-small gap is $D(a)=\mu_l(a)-\mu_s(a)$, so its closure is \[ \Gamma=D(0)-D(1)=\tau_s-\tau_l. \tag{1} \] This identity fixes the sign convention. A positive value means the average gap narrows, not that every small firm catches up.

Aggregate value additionally subtracts real research and program costs and includes entry, competition, and diffusion under a declared boundary. A smaller group gap is neither necessary nor sufficient for positive total welfare.

A private research-investment model

Each group consists of identical firms in this benchmark. A firm with productivity parameter $\theta_g>0$ chooses additional research input $k\ge0$. The package contributes common free-to-the-firm input $a\ge0$, where the two regimes are $a=0$ and a fixed positive $a=A$. Validated product value is \[ Y_g(a,k)=\theta_g\log(1+a+k). \] Private research costs $c_gk$ in real resources, with $c_g>0$. Founders capture product value and maximize $Y_g-c_gk$. There are no product-market spillovers or upstream innovation responses.

Proposition: The unique optimal private input is \[ k_g(a)=\max\{0,\theta_g/c_g-1-a\}. \tag{2} \] Where $k_g(a)>0$, package input crowds out private input one for one and validated output is constant in $a$. On an open range where $k_g(a)=0$, output rises with derivative $\theta_g/(1+a)$. At a switch from positive input to zero input, this is the right derivative; the two-sided derivative need not exist.
Proof: The objective has derivative $\theta_g/(1+a+k)-c_g$ and strictly negative second derivative. Its unconstrained stationary point is $\theta_g/c_g-1-a$; truncating at zero gives the constrained optimum. In the interior, total input $1+a+k_g(a)$ equals $\theta_g/c_g$, establishing constant output and the crowd-out derivative. At the boundary, substitute $k=0$ to obtain the stated output derivative. ∎
The result distinguishes validated output from net gains. Even when output is unchanged, a firm can save real private research resources. Counting only new products would miss that gain. Conversely, using subsidized compute rather than private compute need not save resources if public provision is more costly.

A worked gap closure with either welfare sign

Take $\theta_s=\theta_l=1$, $c_s=2$, $c_l=1/4$, and package $A=1$. The small firm has $k_s(0)=k_s(1)=0$; its product value rises from zero to $\log2$. The incumbent reduces input from three to two; its value remains $\log4$. Therefore \[ \tau_s=\log2,\quad \tau_l=0,\quad \Gamma=\log2>0. \] The baseline output gap is $\log4$, and the treated gap is $\log2$, consistent with (1).

Suppose the two groups have equal mass and providing the package uses resource cost $C_A$ per eligible firm. Average product value rises by $(\log2)/2$. Average private research resource use falls by $(1/2)(1/4)=1/8$. Thus aggregate net value per firm changes by \[ \Delta W=\frac{\log2}{2}+\frac18-C_A. \tag{3} \] At $C_A=0.4$, this is approximately $0.0716>0$; at $C_A=0.6$, it is approximately $-0.1284<0$. The group gap closes equally in both cases. These are constructed parameter checks, not estimates of an existing AI program.

The example holds initial capability constant and makes substitution between package input and private input explicit. Its small firms face high private input costs; incumbents can already reach their desired scale. In another economy incumbents may have larger marginal commercialization opportunities, giving $\tau_l>\tau_s$. No sign follows from an access label alone.

What an access lottery identifies

Suppose package assignment $Z$ is randomized with known probabilities strictly between zero and one within each baseline group, independently of all potential outcomes. Consistency gives \[ \tau_g={\mathbb{E}}[Y\mid Z=1,G=g]-{\mathbb{E}}[Y\mid Z=0,G=g]. \tag{4} \] The proof is simply randomization replacing each conditional observed mean by its potential mean in that fixed group. Subtracting the two identified effects gives $\Gamma$ without an exclusion restriction about actual use.

If only a subset uses the package, (4) still identifies assignment effects including nonuse. A Wald ratio dividing by uptake changes additionally needs exclusion, monotone uptake, and a nonzero first stage. Its local effect pertains to group-specific compliers. Comparing two such local effects compares potentially different populations and does not automatically identify the gap closure in (1).

Grouping firms by their size after treatment would also alter the target: successful small firms might move into the large group. Baseline classification avoids that reclassification bias. Failed firms must remain in the cohort, with validated value zero and their real failed-research expenditures retained in costs.

A simultaneous certificate

For a simple independent-firm experiment with no spillovers, suppose each of the four group-assignment cells has $n_{ga}$ observations and outcome $Y\in[0,M]$. Define \[ e_{ga}=M\sqrt{\log(8/\alpha)/(2n_{ga})}. \] A bounded-mean tail inequality and a union bound give, with probability at least $1-\alpha$, all four cell means within their corresponding errors. Hence an estimated gap closure has absolute error at most $\sum_{g,a}e_{ga}$. A strictly positive lower endpoint certifies gap closure within this model; a merely positive point estimate does not.

For aggregate net value, conduct the randomization at a market level if firms compete or share knowledge. Define each market outcome to include all baseline firms' validated value, relevant displaced product value under the declared accounting boundary, and actual research and program resources. Independent market means then identify the total policy contrast. The outcome may differ from the sum of isolated treated firms' gains. A simultaneous confidence event for gap closure and market value can certify both inequalities, but its assignment design and dependence assumptions must support that joint event.

Limits and remaining question

The investment solution is exact under logarithmic benefits, constant private research cost, and no spillovers. It does not establish actual commercialization values, compute quality, ownership weights, consumer surplus, or incumbent competitive responses. The statistical identities identify only the implemented package and observed population under the design assumptions.

The broader question of which arrangements simultaneously democratize innovation and raise aggregate value therefore remains unresolved. This attempt supplies a concrete mechanism and a sign reversal that an empirical design must distinguish, rather than assuming that adoption or gap closure measures welfare.

Completion Estimate

50%

This is a post hoc, heuristic estimate for the full catalogue target. The attempt solves a research-input crowd-out model, demonstrates gap closure with either aggregate-value sign, and derives access-lottery identification and simultaneous certificates. Full innovation democratization still requires validated commercialization values and resource costs, market-wide knowledge and competition responses, and evidence selecting support arrangements that achieve both objectives.

References

Go to contribution →